Erratum to: The role of raf kinase inhibitor protein in rheumatoid fibroblast-like synoviocytes invasiveness and cytokine and matrix metalloproteinase expression (Inflammation DOI: 10.1007/s10753-011-9336-2);The role of Raf kinase inhibitor protein in rheumatoid fibroblast-like synoviocytes invasiveness and cytokine and matrix metalloproteinase expression

Inflammation

Volumn 35, Issue 2, 2012, Pages 474-483

  Ahn, Joong Kyong ^a   Hwang, Ji Won ^b   Bae, Eun Kyung ^c   Lee, Jaejoon ^b   Jeon, Chan Hong ^d   Koh, Eun Mi ^b   Cha, Hoon Suk ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Cytokines; Fibroblast like synoviocytes; Matrix metalloproteinase; Raf kinase inhibitor protein; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PLASMID VECTOR; SMALL INTERFERING RNA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; FIBROBLAST LIKE SYNOVIOCYTE; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PATHOGENESIS; PLASMID; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

EID: 84863777245     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9351-3     Document Type: Erratum

References (24)

1. Muller-Ladner, U., and S. Gay. 2002. MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction? Annals of the Rheumatic Diseases 61: 957-959. (Pubitemid 35221681)
2. Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361. (Pubitemid 40852711)
3. Huber, L.C., O. Distler, I. Tarner, R.E. Gay, S. Gay, and T. Pap. 2006. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 45: 669-675. (Pubitemid 43985334)
4. Stebulis, J.A., R.G. Rossetti, F.J. Atez, and R.B. Zurier. 2005. Fibroblast-like synovial cells derived from synovial fluid. The Journal of Rheumatology 32: 301-306. (Pubitemid 40209130)
5. Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews 233: 233-255.
6. Klysik, J., S.J. Theroux, J.M. Sedivy, J.S. Moffit, and K. Boekelheide. 2008. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cellular Signalling 20: 1-9. (Pubitemid 350138364)
7. Zeng, L., A. Imamoto, and M.R. Rosner. 2008. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opinion on Therapeutic Targets 12: 1275-1287.
8. Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315-324. (Pubitemid 18091653)
9. Ahn, J.K., E.M. Koh, H.S. Cha, Y.S. Lee, J. Kim, E.K. Bae, and K.S. Ahn. 2008. Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47: 834-839. (Pubitemid 351796369)
10. Cha, H.S., E.K. Bae, J.K. Ahn, J. Lee, K.S. Ahn, and E.M. Koh. 2010. Slug suppression induces apoptosis via Puma transactivation in rheumatoid arthritis fibroblast-like synoviocytes treated with hydrogen peroxide. Experimental & Molecular Medicine 42: 428-436.
11. Yeung, K., T. Seitz, S. Li, P. Janosch, B. McFerran, C. Kaiser, F. Fee, K.D. Katsanakis, D.W. Rose, H. Mischak, J.M. Sedivy, and W. Kolch. 1999. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401: 173-177. (Pubitemid 29436321)
12. Li, Q., and I.M. Verma. 2002. NF-kappaB regulation in the immune system. Nature Reviews. Immunology 2: 725-734.
13. Yeung, K.C., D.W. Rose, A.S. Dhillon, D. Yaros, M. Gustafsson, D. Chatterjee, B. McFerran, J. Wyche, W. Kolch, and J.M. Sedivy. 2001. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Molecular and Cellular Biology 21: 7207-7217. (Pubitemid 32953475)
14. Fu, Z., Y. Kitagawa, R. Shen, R. Shah, R. Mehra, D. Rhodes, P.J. Keller, A. Mizokami, R. Dunn, A.M. Chinnaiyan, Z. Yao, and E.T. Keller. 2006. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. The Prostate 66: 248-256. (Pubitemid 43191224)
15. Schuierer, M.M., F. Bataille, S. Hagan, W. Kolch, and A.K. Bosserhoff. 2004. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Research 64: 5186-5192. (Pubitemid 39006537)
16. Fu, Z., I.M. Dozmorov, and E.T. Keller. 2002. Osteoblasts produce soluble factors that induce a gene expression pattern in nonmetastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. The Prostate 51: 10-20. (Pubitemid 34274855)
17. Fu, Z., P.C. Smith, L. Zhang, M.A. Rubin, R.L. Dunn, Z. Yao, and E.T. Keller. 2003. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. Journal of the National Cancer Institute 95: 878-889. (Pubitemid 36833879)
18. Yamanishi, Y., and G.S. Firestein. 2001. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheumatic Diseases Clinics of North America 27: 355-371. (Pubitemid 32488710)
19. Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. Journal of Clinical Investigation 108: 73-81. (Pubitemid 32634924)
20. Sweeney, S.E., and G.S. Firestein. 2007. Primer: signal transduction in rheumatic disease-a clinician's guide. Nature Clinical Practice. Rheumatology 3: 651-660. (Pubitemid 350031754)
21. Beshir, A. B., G. Ren, A. N. Magpusao, L. M. Barone, K. C. Yeung, and G. Fenteany. 2010. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Letter 299: 137-149.
22. Li, H.Z., Y. Gao, X.L. Zhao, Y.X. Liu, B.C. Sun, J. Yang, and Z. Yao. 2009. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Molecular Cancer Research 7: 832-840.
23. Hong, T., and L.B. Grabel. 2006. Migration of F9 parietal endoderm cells is regulated by the ERK pathway. Journal of Cellular Biochemistry 97: 1339-1349.
24. Wada, A., K. Fukui, Y. Sawai, K. Imanaka, S. Kiso, S. Tamura, I. Shimomura, and N. Hayashi. 2006. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma. Journal of Hepatology 44: 142-150. (Pubitemid 41772528)